917
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Association of high sensitive C reactive protein and dialysis adequacy with uremic pruritus in hemodialysis patients

, ORCID Icon, & ORCID Icon
Pages 111-117 | Received 03 Apr 2020, Accepted 16 Jun 2020, Published online: 05 Jul 2020

References

  • Tayyebi A, Samanehshasti TD, Eynollahi B, et al. The relationship between blood pressure and dialysis adequacy in dialysis patients. Iran J Crit Care Nurs. 2012;5(1):49–52.
  • Rocco MV, Lockridge RS Jr, Beck GJ, et al. The effects of frequent nocturnal home hemodialysis: the frequent hemodialysis network nocturnal trial. Kidney Int. 2011;80(10):1080–1091.
  • Amini M, Aghighi M, Masoudkabir F, et al. Hemodialysis adequacy and treatment in Iranian patients: a national multicenter study. Iran J Kidney Dis. 2011;5(2):103–109.
  • Ko MJ, Wu HY, Chen HY, et al. Uremic pruritus, dialysis adequacy, and metabolic profiles in hemodialysis patients: a prospective 5-year cohort study. PLoS One. 2013;8(10):e71404.
  • Narita I, Alchi B, Omori K, et al. Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients. Kidney Int. 2006;69(9):1626–1632.
  • Rayner H, Baharani J, Smith S, et al. Uraemic pruritus: relief of itching by gabapentin and pregabalin. Nephron Clin Pract. 2013;122(3–4):75–79.
  • Manenti L. Tansinda P and Vaglio A. Uraemic pruritus: clinical characteristics, pathophysiology and treatment. Drugs. 2009;69(3):251–263.
  • Bazzino O, Ferreiros ER, Pizarro R, et al. C-reactive protein and the stress tests for the risk stratification of patients recovering from unstable angina pectoris. Am J Cardiol. 2001;87(11):1235–1239.
  • Weinstein R, Kershaw G, Bailey J, et al. Safety and efficacy of autologous hemopoietic progenitor cell collection in tandem with hemodialysis in multiple myeloma with myeloma cast nephropathy. J Clin Apher. 2014;29(2):83–89.
  • Ashmore SD, Jones CH, CG N, et al. Ondansetron therapy for uremic pruritus in maintenance hemodialysis patients. Am J Kidney Dis. 2000;35(5):827–831.
  • Pauli-Magnus C, Mikus G, Alscher DM, et al. Naltrexone does not relieve uremic pruritus: results of a randomized, placebo-controlled crossoverstudy. J Am Soc Nephrol. 2000;11(3):514–519.
  • Snit M, Gawlik R, Lacka-Gazdzik B, et al. Substance P and intensity of pruritus in hemodialysis and peritoneal dialysis patients. Med Sci Monit. 2013;19:723–732.
  • Fallahzadeh MK, Roozbeh J, Geramizadeh B, et al. Interleukin-2 serum levels are elevated in patients with uremic pruritus: A novel finding with practical implications. Nephrol Dial Transplant. 2011;26(10):3338–3344.
  • Razeghi E. Tavakolizadeh S and Ahmadi F. Inflammation and pruritus in hemodialysis patients. Saudi J Kidney Dis Transpl. 2008;19:62–66.
  • Mettang T, Krumme B, Bohler J, et al. Pentoxifylline as treatment for uraemic pruritus-an addition to the weak armentarium for a common clinical symptom? Nephrol Dial Transplant. 2007;22:2727–2728.
  • Aoki R, Kawamura T, Goshima F, et al. Mast cells play a key role in host defense against herpes simplex virus infection through TNF-α and IL-6 production. J Invest Dermatol. 2013;133(9):2170–2179.
  • Mettang T, Pauli-Magnus C, Alscher DM. Uraemic pruritus - new perspectives and insights from recent trials. Nephrol Dial Transplant. 2002;17(9):1558–1563.
  • Welter Ede Q, Frainer RH, Maldotti A, et al. Evaluating the association between alterations in mineral metabolism and pruritus in hemodialysis patients. A Bras Dermatol. 2011;86(1):31–36.
  • Narita I, Iguchi S, Omori K, et al. Uremic pruritus in chronic hemodialysis patients. J Nephrol. 2008;21(2):161–165.
  • Pisoni RL, Wikstrom B, Elder SJ, et al. Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2006;21(12):3495–3505.
  • Kimata N, Fuller DS, Saito A, et al. Pruritis in hemodialysis patients: results from the Japanese Dialysis Outcomes and Practice Patterns StudyO (JDOPPS). Hemodial Int. 2014 Jul;18(3):657–667.
  • Ramakrishnan K, Bond TC, Claxton A, et al. Clinical characteristics and outcomes of end-stage renal disease patients with self-reported pruritus symptoms. Int J Nephrol Renovasc Dis. 2013;7:1–12.
  • Chen YH, Hung SC, Tarng DC. Serum bilirubin links UGT1A1*28 polymorphism and predicts long‐term cardiovascular events and mortality in chronic hemodialysis patients. Clin J Am Soc Nephrol. 2011;6(3):567–574.